These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26160431)

  • 1. Novel Functions of the Anticoagulant Activated Protein C in Maintaining Skin Barrier Integrity to Impact on Skin Disease.
    Xue M; Jackson CJ
    Pathobiology; 2015; 82(2):100-6. PubMed ID: 26160431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated protein C: A regulator of human skin epidermal keratinocyte function.
    McKelvey K; Jackson CJ; Xue M
    World J Biol Chem; 2014 May; 5(2):169-79. PubMed ID: 24921007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The skin's barrier.
    Jensen JM; Proksch E
    G Ital Dermatol Venereol; 2009 Dec; 144(6):689-700. PubMed ID: 19907407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flightless I over-expression impairs skin barrier development, function and recovery following skin blistering.
    Kopecki Z; Yang GN; Arkell RM; Jackson JE; Melville E; Iwata H; Ludwig RJ; Zillikens D; Murrell DF; Cowin AJ
    J Pathol; 2014 Apr; 232(5):541-52. PubMed ID: 24375017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filaggrin and the great epidermal barrier grief.
    McGrath JA
    Australas J Dermatol; 2008 May; 49(2):67-73; quiz 73-4. PubMed ID: 18412804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal tight junction barrier function is altered by skin inflammation, but not by filaggrin-deficient stratum corneum.
    Yokouchi M; Kubo A; Kawasaki H; Yoshida K; Ishii K; Furuse M; Amagai M
    J Dermatol Sci; 2015 Jan; 77(1):28-36. PubMed ID: 25511077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated protein C--an anticoagulant that does more than stop clots.
    Jackson CJ; Xue M
    Int J Biochem Cell Biol; 2008; 40(12):2692-7. PubMed ID: 18249579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipase Cδ1 regulates p38 MAPK activity and skin barrier integrity.
    Kanemaru K; Nakamura Y; Totoki K; Fukuyama T; Shoji M; Kaneko H; Shiratori K; Yoneda A; Inoue T; Iwakura Y; Kabashima K; Fukami K
    Cell Death Differ; 2017 Jun; 24(6):1079-1090. PubMed ID: 28430185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidermal barrier disorders in dermatoses].
    Proksch E; Dähnhardt D; S Dähnhardt-Pfeiffer ; Fölster-Holst R
    Hautarzt; 2016 Nov; 67(11):907-921. PubMed ID: 27770133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial protein C receptor and protease-activated receptor-1 mediate induction of a wound-healing phenotype in human keratinocytes by activated protein C.
    Xue M; Campbell D; Sambrook PN; Fukudome K; Jackson CJ
    J Invest Dermatol; 2005 Dec; 125(6):1279-85. PubMed ID: 16354200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminases in skin epidermis.
    Hitomi K
    Eur J Dermatol; 2005; 15(5):313-9. PubMed ID: 16172037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical application of TRPM8 agonists accelerates skin permeability barrier recovery and reduces epidermal proliferation induced by barrier insult: role of cold-sensitive TRP receptors in epidermal permeability barrier homoeostasis.
    Denda M; Tsutsumi M; Denda S
    Exp Dermatol; 2010 Sep; 19(9):791-5. PubMed ID: 20636355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation.
    Bonnet MC; Preukschat D; Welz PS; van Loo G; Ermolaeva MA; Bloch W; Haase I; Pasparakis M
    Immunity; 2011 Oct; 35(4):572-82. PubMed ID: 22000287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of epidermal keratinocytes is dependent on glucosylceramide:ceramide processing.
    Amen N; Mathow D; Rabionet M; Sandhoff R; Langbein L; Gretz N; Jäckel C; Gröne HJ; Jennemann R
    Hum Mol Genet; 2013 Oct; 22(20):4164-79. PubMed ID: 23748427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal inactivation of the glucocorticoid receptor triggers skin barrier defects and cutaneous inflammation.
    Sevilla LM; Latorre V; Sanchis A; Pérez P
    J Invest Dermatol; 2013 Feb; 133(2):361-70. PubMed ID: 22951731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regulation of the epidermal permeability barrier by lipids and hyperproliferation].
    Proksch E
    Hautarzt; 1992 Jun; 43(6):331-8. PubMed ID: 1628964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal tight junctions: ZO-1 and occludin are expressed in mature, developing, and affected skin and in vitro differentiating keratinocytes.
    Pummi K; Malminen M; Aho H; Karvonen SL; Peltonen J; Peltonen S
    J Invest Dermatol; 2001 Nov; 117(5):1050-8. PubMed ID: 11710912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin aging, gene expression and calcium.
    Rinnerthaler M; Streubel MK; Bischof J; Richter K
    Exp Gerontol; 2015 Aug; 68():59-65. PubMed ID: 25262846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated protein C stimulates proliferation, migration and wound closure, inhibits apoptosis and upregulates MMP-2 activity in cultured human keratinocytes.
    Xue M; Thompson P; Kelso I; Jackson C
    Exp Cell Res; 2004 Sep; 299(1):119-27. PubMed ID: 15302579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery.
    Jeong SK; Kim HJ; Youm JK; Ahn SK; Choi EH; Sohn MH; Kim KE; Hong JH; Shin DM; Lee SH
    J Invest Dermatol; 2008 Aug; 128(8):1930-9. PubMed ID: 18305573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.